Company Cann American Corp.

CNNA

US13764N2071

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - OTC Markets Other stock markets 15:59:54 2024-05-10 EDT			5-day change	1st Jan Change
0.003 ^USD	+50.00%		+25.00%	-25.00%

2023	Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	CI
2023	Cann American Corp. Auditor Raises 'Going Concern' Doubt	CI

Cann American Corp. is a holding company. The Company is engaged in developing assets within the legal cannabis and hemp industries. The Company has two subsidiaries, Cannequipt, LLC and Hourglass Enterprises LLC. Cannequipt, LLC, intends to act as a research and development division. Hourglass Enterprises LLC, intends to focus on developing new assets in the state of Oklahoma. The Company primarily within the state of California.

Number of employees: 1

Managers	Title	Age	Since
Jason Tucker CEO	Chief Executive Officer	-	23-01-31

Members of the board	Title	Age	Since
Jason Tucker CEO	Chief Executive Officer	-	23-01-31
Pete Caruso BRD	Director/Board Member	-	23-02-28
Michael Kramer BRD	Director/Board Member	-	23-05-09

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	261,666,851	259,050,183 ( 99.00 %)	0	99.00 %

Cann American Corp.

75 Union Avenue

07070, Rutherford

+770-866-6250

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
CANN AMERICAN CORP.	-25.00%	2.21M
ELI LILLY AND COMPANY	+30.38%	684B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.36%	361B
MERCK & CO., INC.	+19.30%	329B
ABBVIE INC.	+3.73%	284B
ASTRAZENECA PLC	+16.70%	240B
NOVARTIS AG	+8.78%	208B
ROCHE HOLDING AG	-7.93%	200B
AMGEN INC.	+7.68%	166B

Other Pharmaceuticals